Jun 29, 2026 07:00AM
May 5, 2026 01:00AM
Apr 30, 2026 01:00AM
Apr 28, 2026 01:01AM
Jan 8, 2026 02:16AM
Sep 23, 2025 02:29AM
Aug 13, 2025 01:00AM Santhera Secures Agreement with GEN for the Distribution of AGAMREE® (Vamorolone) in Türkiye
Jan 14, 2025 01:00AM
Jan 6, 2025 01:00AM
Oct 1, 2024 01:00AM
Sep 12, 2024 01:00AM
Jun 18, 2024 01:15AM
Jun 10, 2024 01:00AM
Apr 25, 2024 01:00AM Santhera Announces Preliminary Unaudited 2023 Annual Results and Provides Corporate Update Ahead of Full Report Publication in May
Dec 18, 2023 01:00AM
Jul 31, 2023 01:00AM
Jun 29, 2023 01:00AM
May 31, 2023 05:50PM
Apr 27, 2023 01:00AM
Apr 25, 2023 01:00AM
Mar 2, 2023 01:00AM Santhera Submits Marketing Authorization Application to the UK MHRA for Vamorolone in Duchenne Muscular Dystrophy
Feb 28, 2023 01:00AM
Feb 8, 2023 01:00AM
Jan 10, 2023 01:00AM
Jan 9, 2023 01:00AM
Nov 29, 2022 05:45AM
Nov 4, 2022 02:00AM
Oct 31, 2022 02:05AM European Medicines Agency Validates Santhera’s Marketing Authorization Application for Vamorolone in Duchenne Muscular Dystrophy
Oct 31, 2022 02:00AM
Oct 27, 2022 01:00AM
Oct 10, 2022 01:00AM
Oct 3, 2022 01:00AM
Sep 29, 2022 01:00AM
Sep 1, 2022 01:00AM
Aug 22, 2022 01:00AM Santhera and ReveraGen Announce First Participant Dosed in FDA-funded Phase 2 Pilot Study with Vamorolone in Becker Muscular Dystrophy
Jun 30, 2022 11:45AM
Jun 29, 2022 01:00AM
Jun 27, 2022 02:25PM
Jun 10, 2022 01:00AM
Jun 9, 2022 01:00AM
Jun 3, 2022 11:45AM
Jun 2, 2022 01:00AM Santhera Announces Improved Liquidity Position
Apr 29, 2022 01:00AM
Apr 13, 2022 01:00AM
Mar 29, 2022 01:00AM
Mar 15, 2022 02:05AM
Mar 15, 2022 02:00AM
Mar 11, 2022 01:00AM
Feb 28, 2022 01:00AM Santhera Signs Gene Therapy Agreement with SEAL Therapeutics
Feb 18, 2022 01:00AM

326,296 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All